Overview
Won-jin Park practices practicing medicine in Daegu, Republic of Korea.
Their clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Non-Small Cell Lung Cancer (NSCLC), and Colorectal Cancer.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Won-jin Park
Is Won-jin Park a top-rated expert for PIK3CA-Related Overgrowth Spectrum?
MediFind is an objective health platform that identifies experts based on real-world data. Won-jin Park is classified as an Experienced expert for PIK3CA-Related Overgrowth Spectrum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Won-jin Park participate in research or clinical trials?
Yes. Won-jin Park has published 18 articles and abstracts on conditions like PIK3CA-Related Overgrowth Spectrum. You can view a list of Won-jin Park's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerPark isExperienced. Learn about Colorectal Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- PIK3CA-Related Overgrowth Spectrum